Antenatal bartter syndrome: Analysis of two cases with placental findings

Fetal and Pediatric Pathology

Volumn 29, Issue 3, 2010, Pages 121-126

  Dane, Banu ^a   Dane, Cem ^a   Aksoy, Figen ^b   Cetin, Ahmet ^a   Yayla, Murat ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Bartter syndrome; Nephrocalcinosis; Polyhydramnios; Prenatal diagnosis

Indexed keywords

ALDOSTERONE; CALCIUM; CHLORIDE; INDOMETACIN; POTASSIUM CHLORIDE; RENIN; SODIUM;

ADULT; AMNIOCENTESIS; AMNION FLUID ANALYSIS; ARTICLE; BARTTER SYNDROME; CASE REPORT; CESAREAN SECTION; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HUMAN; HYDRAMNIOS; HYPOKALEMIA; KIDNEY CALCIFICATION; MICROSCOPY; POLYURIA; PREMATURE FETUS MEMBRANE RUPTURE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; URINARY EXCRETION;

ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTERIOSCLEROSIS; BARTTER SYNDROME; CHLORIDES; CHORIONIC VILLI; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; MALE; NEPHROCALCINOSIS; PLACENTA DISEASES; POLYHYDRAMNIOS; POTASSIUM CHLORIDE; PREGNANCY; TREATMENT OUTCOME;

EID: 77952134513     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.3109/15513811003777276     Document Type: Article

References (15)

1. Bartter FC, Pronove P, Gill JR, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 33;811-828, 1962.
2. Schwarz I, Alon U. Bartter syndrome revisited. J Nephrol 9:81-87, 1996.
3. Massa G, Proesmans W, Devlieger H, Vandenberghe K, Van Assche A, Eggermont E. Electrolyte composition of the amniotic fluid in Bartter Syndrome. Eur J Obstet Gynecol Reprod Biol 24:335-340, 1987.
4. Konrad M, Leonhardt A,Hensen P, SeyberthHW, Köckerling A. Prenatal and postnatalmanagement of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes. Pediatrics 103:678-683, 1999.
5. Ernst LM, Parkash V. Placental pathology in fetal Bartter syndrome. Pediatr Dev Pathol 5:76-79, 2002.
6. Benzie RJ, Doran TA, Harkins JL, Owen VM, Porter CJ. Composition of the amniotic fluid and maternal serum in pregnancy. Am J Obstet Gynecol 119:798-810, 1974.
7. Doyle NM, Gardner MO, Wells L, Qualls C, Papile LA. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis. J Perinatol 25:336-340, 2005.
8. Ojala R, Ikonen S, Tammela O. Perinatal indomethacin treatment and neonatal complications in preterm infants. Eur J Pediatr 159:153-155, 2000.
9. Hwang H, Murphy JJ, Gow KW, Magee JF, Bekhit E, Jamieson D. Are localized intestinal perforations distinct from necrotizing enterocolitis? J Pediatr Surg 38:763-767, 2003.
10. Kawase Y, Ishii T, Arai H, Uga N. Gastrointestinal perforation in very low-birthweight infants. Pediatr Int 48:599-603, 2006.
11. Tarrado X, Castanon M, Thio M, Valderas JM, Garcia Aparicio L, Morales L. Comparative study between isolated intestinal perforation and necrotizing enterocolitis. Eur J Pediatr Surg 15:88-94, 2005.
12. Buchheit JQ, Stewart DL. Clinical comparison of localized intestinal perforation and necrotizing entercolitis in neonates. Pediatrics 93:32-36, 1994.
13. Stark AR, CarloWA, Tyson JE, Papile LA,Wright LL, Shankaran S,Donovan EF,OhW, BauerCR, Saha S. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 344:95-101, 2001.
14. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: Facts and controversies. Placenta 27:939-958, 2006.
15. Redline RW, Wilson-Costello D, Hack M. Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 52:713-719, 2002.